$46.30

0.21 (0.46%)

2/9/2010 4:00 PM

Gilead Sciences, Inc. (GILD)

CAPS Rating:

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GILD

Add Stock to Watchlist

What the Community Thinks

Total Members

1798 Outperforms

57 Underperforms

All-Stars

532 Outperforms

14 Underperforms

Wall Street

30 Outperforms

1 Underperforms

Members bullish on GILD are also bullish on:

Members bearish on GILD are also bearish on:

Ticker Tags

Defensive (1457), Large Cap (413), Biotechnology (220), S&P 500 (499), Growth (1902), Business Week 50 (48), Healthcare (711), California (37), Nasdaq 100 (85)
Suggest a tag

Gilead Sciences, Inc. At A Glance

Current Price:	$46.30
Last Trade Time:	2/9/2010 4:00 PM
Open:	$46.57
Previous Close:	$46.09
Daily Range:	$46.05 - $47.00
52-Week Range:	$40.62 - $52.29
Volume:	9,495,990
Market Cap:	$41.67B
P/E Ratio:	15.84
Compare Our Special Broker Offers!

Stock Trends

GILD VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for GILD

'Mad Money Lightning Round': Visa Rocks
2/8/2010 7:33:26 PM -
Cramer's 'Mad Money' Recap: The Lure of Semiconductor Stocks (Final)
2/8/2010 7:24:02 PM -
($) Biotech ETFs Are Looking Healthy
2/8/2010 4:50:11 PM -
Director William Furman Buys $2.1M Worth of Schnitzer Steel
2/8/2010 10:58:26 AM -

More Headlines...

Top Bull Pitch

Recs

6 Gilead Sciences, Inc. (GILD)

Avatar mrindependent (99.29) Submitted: 12/10/09 7:41 PM

I noticed Gilead Sciences in my best 25 large cap pe/roe screen. This screen has outperformed the market by about 15% per year during the last 9 years. Gilead is swimming in cash and boasts a 5 yr average historical roe of 49%. The company is swimming in cash. Sales growth has been spectacular f...More

Replies: 2 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 234 : 1 2 3 4 5 Next » Jump to page:

Recs 0 (GILD) EBStroke (< 20) Submitted: 2/08/10 12:04 PM : Start Price: $46.25 GILD Score: -0.13 Zacks Rank 1-StrongBuy, Recommend Outperform, Industry Rank 132 / 217, Target 52.50, Avg Target of 29 analysts 55.92 Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (GILD) richardrogers4 (65.05) Submitted: 2/03/10 3:57 AM : Start Price: $48.22 GILD Score: -1.56 Technical breakout Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (GILD) kpoeppel (32.03) Submitted: 2/02/10 11:57 PM : Start Price: $48.22 GILD Score: -1.56 Great earnings growth during the last two years, yet no sustained increase in the stock price since October of '08. Price should begin to move upwards to track earnings. Drugs and biotech are a good industry given aging populations in the developed world. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (GILD) ColeKellas (94.87) Submitted: 2/02/10 2:00 PM : Start Price: $48.42 GILD Score: -1.63 Good growth potential considering the size of the company. One of 15 that I own in real life. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (GILD) JuanPeter (50.10) Submitted: 2/02/10 2:35 AM : Start Price: $47.65 GILD Score: -0.97 Nice stock with not bad financial ratios i.e. nice P/E but somewhat higher P/B and P/S. Don´t expect it to skyrocket, but you may get some good profitability out of it at the end of the year. Will see what happens next feb 13 when the FDA has to decide on Cayston approval for cystic fibrosis. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 234 : 1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 31 of 31

picks per page. CHANGE Expand All Pitches Collapse All Pitches

Top Pick	Member Name	Member Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackWedbush	66.12	10/21/09		NS	$45.27	+2.28%	-1.67%	-3.94
	TrackMorganJos	< 20	04/22/09		NS	$46.23	+0.15%	+28.48%	-28.33
	TrackThinkEquity	64.82	04/14/09		NS	$47.25	-2.01%	+27.41%	-29.42
	TrackStanfordRes	85.54	12/23/08		NS	$50.13	-7.64%	+24.67%	-32.31
	TrackMerriman	< 20	12/15/08		NS	$44.95	+3.00%	+23.57%	-20.57
	TrackNeedham	67.64	11/12/08		NS	$43.90	+5.47%	+24.70%	-19.24
	TrackBofASec	94.61	10/24/08		NS	$42.81	+8.15%	+30.66%	-22.50
	TrackBMOCapital	91.22	10/17/08		NS	$42.91	+7.90%	+17.29%	-9.39
	TrackRWBaird	87.00	09/12/08		NS	$49.42	-6.31%	-11.01%	+4.70
	TrackLadenburg	80.62	07/18/08		NS	$49.81	-7.05%	-11.98%	+4.93
	TrackDeutscheSec	89.68	06/19/08		NS	$53.17	-12.92%	-17.10%	+4.18
	TrackPacificGrow	89.01	05/21/08		NS	$52.57	-11.93%	-20.39%	+8.46
	TrackOppenheimer	81.36	04/17/08		NS	$50.99	-9.20%	-18.35%	+9.15
	TrackJimCramer	< 20	04/02/08		3W	$51.90	-10.79%	-18.72%	+7.93
	TrackDodgeCox	90.73	03/31/08		NS	$51.53	-10.15%	-15.75%	+5.60
	TrackWellsFargo	80.02	01/31/08		NS	$44.88	+3.16%	-16.23%	+19.40
	TrackCreditSuiss	93.62	01/07/08		NS	$46.83	-1.13%	-21.16%	+20.02
	TrackEdwardOwens	98.91	09/30/07		NS	$40.87	+13.29%	-26.38%	+39.66
	TrackJimJubak	78.84	09/25/07		1Y	$40.72	+13.70%	-25.80%	+39.50
	TrackLeerinkSwan	92.83	04/19/07		NS	$39.49	+17.24%	-22.68%	+39.92
	TrackUBS	87.99	02/21/07		NS	$36.50	+26.85%	-21.85%	+48.70
	TrackPZK	< 20	02/02/07		NS	$35.50	+30.42%	-21.37%	+51.79
	TrackStifel	96.44	02/01/07		NS	$34.95	+32.47%	-21.05%	+53.52
	TrackJMP	71.98	02/01/07		NS	$34.95	+32.47%	-21.05%	+53.52
	TrackBroadpoint.AmTech	76.97	12/19/06		NS	$31.86	+45.32%	-19.53%	+64.85
	TrackRodmanRen	< 20	12/04/06		NS	$32.90	+40.73%	-18.86%	+59.59
	TrackLazardCapit	< 20	11/22/06		NS	$33.80	+36.98%	-19.20%	+56.19
	TrackRBCCapMkts	86.33	09/27/06		NS	$33.44	+38.44%	-14.70%	+53.13
	TrackMontgomery	None	08/16/06		NS	$31.30	+47.95%	-10.65%	+58.60

Results 1 - 31 of 31

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.